Dark

Check out our Dark Pool Levels

TNYA
Tenaya Therapeutics, Inc. Common Stock
stock NASDAQ

Market Open

Oct 2, 2026 2:26:23 PM EDT

0.5600USD-0.495%(-0.0028)3,054,215

0.4900Bid 0.6600Ask 0.1700Spread

Pre-market

Oct 2, 2026 9:21:30 AM EDT

0.5794USD+2.422%(+0.0137)11,484

After-hours

Oct 1, 2026 4:53:30 PM EDT

0.5755USD+2.293%(+0.0129)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 11, 2022

10:38AM EST 52 Weeks High And Low Article Benzinga

Jan 10, 2022

08:30AM EST Tenaya Therapeutics Offers 2022 Business Updates Benzinga

Dec 22, 2021

04:09PM EST Tenaya Therapeutics Appoints Karah Parschauer To Its Board Of Directors RTTNews

04:05PM EST Tenaya Therapeutics Appoints Karah Parschauer, J.D., to Its Board of Directors and Joanna Auch as Senior Vice President of People and Culture Business Wire

Nov 10, 2021

06:12PM EST Tenaya Therapeutics Q3 EPS $(0.68) Up From $(10.29) YoY Benzinga

Oct 20, 2021

08:16AM EDT The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review Benzinga

Oct 18, 2021

07:34AM EDT The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs Benzinga

Oct 13, 2021

01:38PM EDT Tenaya Therapeutics Late Yesterday Announced Co. Will Present Preclinical Data On Its Gene Therapy Programs At The ESGCT 28Th Annual Congress Benzinga

Sep 8, 2021

04:03PM EDT Tenaya Therapeutics Q2 EPS $(13.26) Down From $(9.21) YoY Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

Aug 25, 2021

07:30AM EDT The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug Benzinga

Aug 24, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2021 Benzinga

07:27AM EDT Cowen & Co. Initiates Coverage On Tenaya Therapeutics with Outperform Rating Benzinga

07:24AM EDT Morgan Stanley Initiates Coverage On Tenaya Therapeutics with Overweight Rating, Announces Price Target of $31 Benzinga

06:04AM EDT Chardan Capital Initiates Coverage On Tenaya Therapeutics with Buy Rating, Announces Price Target of $37 Benzinga

05:15AM EDT Piper Sandler Initiates Coverage On Tenaya Therapeutics with Overweight Rating, Announces Price Target of $40 Benzinga

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Jul 30, 2021

10:56AM EDT Tenaya Therapeutics Open For Trade At $19.50; IPO Priced At $15/Share Benzinga

09:18AM EDT Tenaya Therapeutics Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced At $15/Share Benzinga

Jul 29, 2021

11:46PM EDT Tenaya Therapeutics Announces Pricing of Upsized Initial Public Offering Business Wire

Share